These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2475785)

  • 1. Detection of refolding conformers of complement protein C9 during insertion into membranes.
    Laine RO; Esser AF
    Nature; 1989 Sep; 341(6237):63-5. PubMed ID: 2475785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
    Tschopp J; Masson D; Stanley KK
    Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ
    Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
    Kontermann R; Deppisch R; Rauterberg EW
    Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
    Podack ER; Preissner KT; Müller-Eberhard HJ
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes.
    Müller-Eberhard HJ; Zalman LS; Chiu FJ; Jung G; Martin DE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():28-34. PubMed ID: 3612651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the discontinuous epitope in human complement protein C9 recognized by anti-melittin antibodies.
    Laine RO; Esser AF
    J Immunol; 1989 Jul; 143(2):553-7. PubMed ID: 2472443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional studies of the MACPF domain of human complement protein C8alpha reveal sites for simultaneous binding of C8beta, C8gamma, and C9.
    Slade DJ; Chiswell B; Sodetz JM
    Biochemistry; 2006 Apr; 45(16):5290-6. PubMed ID: 16618117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The killer molecule of complement.
    Müller-Eberhard HJ
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):47s-52s. PubMed ID: 3891882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL; Sodetz JM
    Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J; Chonn A; Hertig S; French LE
    J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
    Tomlinson S; Whitlow MB; Nussenzweig V
    J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between polymerization of complement component C9 and membrane channel formation.
    DiScipio RG
    J Immunol; 1991 Dec; 147(12):4239-47. PubMed ID: 1721643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane.
    Hu VW; Esser AF; Podack ER; Wisnieski BJ
    J Immunol; 1981 Jul; 127(1):380-6. PubMed ID: 7240749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T; Meri S
    J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.
    Tschopp J; Podack ER; Müller-Eberhard HJ
    J Immunol; 1985 Jan; 134(1):495-9. PubMed ID: 3964819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW; Shin ML
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
    Deng J; Gold D; LoVerde PT; Fishelson Z
    Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
    Hänsch GM; Schönermark S; Roelcke D
    J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane attack complex of complement in dermatitis herpetiformis.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    Arch Dermatol; 1985 Jan; 121(1):70-2. PubMed ID: 3881089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.